



 {"id":275,"date":"2016-10-03T08:02:18","date_gmt":"2016-10-03T14:02:18","guid":{"rendered":"http:\/\/asipi.org\/?post_type=publicacion&#038;p=919"},"modified":"2022-05-31T02:16:58","modified_gmt":"2022-05-31T02:16:58","slug":"derecho-farmaceutico-vol-i","status":"publish","type":"wpdmpro","link":"https:\/\/staging.asipi.org\/biblioteca\/en\/download\/derecho-farmaceutico-vol-i\/","title":{"rendered":"Pharmaceutical Law Vol. I"},"content":{"rendered":"<h2 style=\"text-align: center;\">Pharmaceutical Law Vol. I<\/h2>\n<p>&nbsp;<\/p>\n<p>For ASIPI it is a great pride to be able to present to you this work that brings together the scientific and legal knowledge of prominent professionals and experts in pharmaceutical or regulatory law in Latin America.<br \/>\nIn each of its six chapters the authors analyze various problems with great depth, so we do not doubt that it will become a permanent reference document for all of us who work with and value intellectual property.<br \/>\nIt is emphasized that these studies are published at a time full of challenges<\/p>\n<h3>Chapter First Intellectual Property and Sanitary Regulation<\/h3>\n<ul>\n<li>&#8220;The contributions of intellectual property and pharmaceutical law to the promotion of health in Latin America&#8221;<strong>F\u00e9lix Rozanski.<\/strong><\/li>\n<li>\u201cBrazilian drug Approval Considerations\u201d <strong>Gustavo de Freitas Morais, Rodrigo Augusto Oliveira Rocci and Vyctor Taddeucci de Araujo.<\/strong><\/li>\n<li>&#8220;Orphan drugs. New challenges in Latin America &#8221; <strong>Andrea V. Robles.<\/strong><\/li>\n<li>&#8220;Evaluation of Andean community cosmetics regulation, 12 years after its entry into force&#8221; <strong>\u00c1lvaro Guti\u00e9rrez Bendez\u00fa.<\/strong><\/li>\n<li>&#8220;Conceptual boundaries of the Right to Protection of Health in International Instruments&#8221; <strong>Hugo Carrasco Soul\u00e9.<\/strong><\/li>\n<li>&#8220;Pharmaceutical Patents, Medicines and Public Health in Paraguay&#8221;<strong>Crist\u00f3bal Gonz\u00e1lez R.<\/strong><\/li>\n<li>&#8220;Pharmaceutical Law. Medical Samples and Free Samples. Analysis of Peruvian and comparative legislation &#8221; <strong>Maritza Re\u00e1tegui Valdiviezo.<\/strong><\/li>\n<\/ul>\n<h3>Chapter Two Biological Products<\/h3>\n<ul>\n<li>&#8220;Some issues related to biological pharmaceuticals in Chile&#8221; <strong>Juan Pablo Ega\u00f1a Bertoglia.<\/strong><\/li>\n<li>&#8220;Biological products. Current Status and Regulation in Peru &#8221; <strong>Jos\u00e9 Jos\u00e1n.<\/strong><\/li>\n<li>&#8220;Approach to the new regulation of the sanitary registry of biological and biotechnological medicines in Colombia &#8211; Decree 1782 of 2014&#8221; <strong>Ana Mar\u00eda Castro and Daniel Cardona.<\/strong><\/li>\n<\/ul>\n<h3>Chapter Three Pharmaceutical Patents<\/h3>\n<ul>\n<li>&#8220;The Argentine regulation of chemical-pharmaceutical inventions: advanced of a continental trend?&#8221; <strong>Mart\u00edn Bensadon e Iv\u00e1n Alfredo Poli.<\/strong><\/li>\n<li>&#8220;Dominican Republic: patent protection through its history&#8221; <strong>Mary Fern\u00e1ndez Rodr\u00edguez.<\/strong><\/li>\n<li>&#8220;Prior Disclosure of an invention: utility of the grace period in the Pharmaceutical industry&#8221; <strong>Marcela Robles.<\/strong><\/li>\n<li>&#8220;Trends that favor the protection of Pharmaceutical Patents. Why patent in Chile? &#8221; <strong>Arturo Covarrubias, Jaime Silva, Daniela Castro and Jos\u00e9 Manuel Delgado.<\/strong><\/li>\n<li>&#8220;The protection of medicines beyond patent law&#8221; <strong>Josep Carbonell.<\/strong><\/li>\n<li>The Exception of the previous user in good faith in the matter of patents: its objective and scope in the Andean Community. <strong>Ana Mar\u00eda Castro and Carolina Hanssen.<\/strong><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Pharmaceutical Law Vol. I &nbsp; For ASIPI it is a great pride to be able to present to you this work that brings together the scientific and legal knowledge of prominent professionals and experts in pharmaceutical or regulatory law in Latin America. In each of its six chapters the authors analyze various problems with great [&hellip;]<\/p>\n","protected":false},"author":3154,"featured_media":430,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"class_list":["post-275","wpdmpro","type-wpdmpro","status-publish","has-post-thumbnail","hentry","wpdmcategory-publicaciones-especializadas"],"_links":{"self":[{"href":"https:\/\/staging.asipi.org\/biblioteca\/en\/wp-json\/wp\/v2\/wpdmpro\/275","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staging.asipi.org\/biblioteca\/en\/wp-json\/wp\/v2\/wpdmpro"}],"about":[{"href":"https:\/\/staging.asipi.org\/biblioteca\/en\/wp-json\/wp\/v2\/types\/wpdmpro"}],"author":[{"embeddable":true,"href":"https:\/\/staging.asipi.org\/biblioteca\/en\/wp-json\/wp\/v2\/users\/3154"}],"replies":[{"embeddable":true,"href":"https:\/\/staging.asipi.org\/biblioteca\/en\/wp-json\/wp\/v2\/comments?post=275"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/staging.asipi.org\/biblioteca\/en\/wp-json\/wp\/v2\/media\/430"}],"wp:attachment":[{"href":"https:\/\/staging.asipi.org\/biblioteca\/en\/wp-json\/wp\/v2\/media?parent=275"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}